The effect of different doses of spirulina on glucose metabolism, lipid profile and blood pressure: a systematic review and meta-analysis of randomized controlled trials
Chaloulakou S, Lympaki F, Tsitsou S, Karagiannakis D, Papakonstantinou E
Published in Clinical Nutrition ESPEN
Methodology
Dose-stratified meta-analysis of randomized trials of spirulina on glycaemic, lipid and blood pressure outcomes.
Key Findings
Lipid and blood pressure improvements were dose dependent, while several glucose metabolism endpoints showed no significant change.
Conclusions
Spirulina benefits cardiometabolic markers unevenly, with glucose outcomes largely unchanged.
Limitations
Dose subgroups were small; heterogeneity high.
Supplements Studied
Spirulina benefits cardiometabolic markers unevenly, with glucose outcomes largely unchanged.
Outcomes Measured
Several glucose metabolism endpoints showed no significant change.
Lipid and blood pressure improvements were dose dependent, while several glucose metabolism endpoints showed no significant change.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.